147 related articles for article (PubMed ID: 38664292)
1. Predicting response to non-selective beta-blockers with liver-spleen stiffness and heart rate in patients with liver cirrhosis and high-risk varices.
Giuffrè M; Dupont J; Visintin A; Masutti F; Monica F; You K; Shung DL; Crocè LS;
Hepatol Int; 2024 Apr; ():. PubMed ID: 38664292
[TBL] [Abstract][Full Text] [Related]
2. Spleen stiffness measurement for assessing the response to β-blockers therapy for high-risk esophageal varices patients.
Marasco G; Dajti E; Ravaioli F; Alemanni LV; Capuano F; Gjini K; Colecchia L; Puppini G; Cusumano C; Renzulli M; Golfieri R; Festi D; Colecchia A
Hepatol Int; 2020 Sep; 14(5):850-857. PubMed ID: 32557193
[TBL] [Abstract][Full Text] [Related]
3. Non-invasive response prediction in prophylactic carvedilol therapy for cirrhotic patients with esophageal varices.
Kim HY; So YH; Kim W; Ahn DW; Jung YJ; Woo H; Kim D; Kim MY; Baik SK
J Hepatol; 2019 Mar; 70(3):412-422. PubMed ID: 30389550
[TBL] [Abstract][Full Text] [Related]
4. Using MR elastography to assess portal hypertension and response to beta-blockers in patients with cirrhosis.
Danielsen KV; Hove JD; Nabilou P; Yin M; Chen J; Zhao M; Kallemose T; Teisner AS; Siebner HR; Ehman RL; Møller S; Bendtsen F
Liver Int; 2021 Sep; 41(9):2149-2158. PubMed ID: 34060714
[TBL] [Abstract][Full Text] [Related]
5. Non-selective β-blockers improve the correlation of liver stiffness and portal pressure in advanced cirrhosis.
Reiberger T; Ferlitsch A; Payer BA; Pinter M; Homoncik M; Peck-Radosavljevic M;
J Gastroenterol; 2012 May; 47(5):561-8. PubMed ID: 22170417
[TBL] [Abstract][Full Text] [Related]
6. Spleen stiffness in patients with cirrhosis in predicting esophageal varices.
Sharma P; Kirnake V; Tyagi P; Bansal N; Singla V; Kumar A; Arora A
Am J Gastroenterol; 2013 Jul; 108(7):1101-7. PubMed ID: 23629600
[TBL] [Abstract][Full Text] [Related]
7. Hemodynamic Response to Carvedilol is Maintained for Long Periods and Leads to Better Clinical Outcome in Cirrhosis: A Prospective Study.
Kirnake V; Arora A; Gupta V; Sharma P; Singla V; Bansal N; Goyal M; Chawlani R; Kumar A
J Clin Exp Hepatol; 2016 Sep; 6(3):175-185. PubMed ID: 27746613
[TBL] [Abstract][Full Text] [Related]
8. The prognostic value of HVPG-response to non-selective beta-blockers in patients with NASH cirrhosis and varices.
Paternostro R; Becker J; Hofer BS; Panagl V; Schiffke H; Simbrunner B; Semmler G; Schwabl P; Scheiner B; Bucsics T; Bauer D; Binter T; Trauner M; Mandorfer M; Reiberger T
Dig Liver Dis; 2022 Apr; 54(4):500-508. PubMed ID: 34799282
[TBL] [Abstract][Full Text] [Related]
9. Risk and Predictors of Variceal Bleeding in Cirrhosis Patients Receiving Primary Prophylaxis With Non-Selective Beta-Blockers.
Shukla R; Kramer J; Cao Y; Ying J; Tansel A; Walder A; Advani S; El-Serag HB; Kanwal F
Am J Gastroenterol; 2016 Dec; 111(12):1778-1787. PubMed ID: 27670600
[TBL] [Abstract][Full Text] [Related]
10. Measuring spleen stiffness to predict varices in chronic hepatitis B cirrhotic patients with or without receiving non-selective beta-blockers.
Wong GL; Kwok R; Chan HL; Tang SP; Lee E; Lam TC; Lau TW; Ma TM; Wong BC; Wong VW
J Dig Dis; 2016 Aug; 17(8):538-546. PubMed ID: 27185358
[TBL] [Abstract][Full Text] [Related]
11. Beta-blockers in liver cirrhosis.
Giannelli V; Lattanzi B; Thalheimer U; Merli M
Ann Gastroenterol; 2014; 27(1):20-26. PubMed ID: 24714633
[TBL] [Abstract][Full Text] [Related]
12. Fibrosis index predicts variceal bleeding and reduces need for nonselective beta-blocker in compensated cirrhosis with initial small esophageal varices without red-color sign.
Wang SF; Huang YT; Huang CH; Chang SH; Lin CY
Ann Transl Med; 2020 Oct; 8(19):1223. PubMed ID: 33178755
[TBL] [Abstract][Full Text] [Related]
13. Application of Noninvasive Tools to Decide the Need for Beta-Blockers for Variceal Bleeding Prophylaxis in Compensated Advanced Liver Disease: A Decision Curve Analysis.
Agarwal S; Sharma S; Jindal A; Singh S; Jagdish R; Gunjan D; Sarin SK; Saraya A
J Clin Exp Hepatol; 2022; 12(3):917-926. PubMed ID: 35677505
[TBL] [Abstract][Full Text] [Related]
14. The longitudinal outcomes of applying non-selective beta-blockers in portal hypertension: real-world multicenter study.
Kang SH; Lee M; Kim MY; Lee JH; Jun BG; Kim TS; Choi DH; Suk KT; Kim YD; Cheon GJ; Kim DJ; Baik SK
Hepatol Int; 2021 Apr; 15(2):424-436. PubMed ID: 33860898
[TBL] [Abstract][Full Text] [Related]
15. Assessment of response to beta-blockers by expression of βArr2 and RhoA/ROCK2 in antrum mucosa in cirrhotic patients.
Trebicka J; von Heydebrand M; Lehmann J; Tofteng F; Busk T; Jensen HL; Rohde J; Reiberger T; Mortensen C; Schierwagen R; Klein S; Møller S; Bendtsen F; Krag A
J Hepatol; 2016 Jun; 64(6):1265-73. PubMed ID: 26827791
[TBL] [Abstract][Full Text] [Related]
16. Spleen stiffness measurement can predict clinical complications in compensated HCV-related cirrhosis: a prospective study.
Colecchia A; Colli A; Casazza G; Mandolesi D; Schiumerini R; Reggiani LB; Marasco G; Taddia M; Lisotti A; Mazzella G; Di Biase AR; Golfieri R; Pinzani M; Festi D
J Hepatol; 2014 Jun; 60(6):1158-64. PubMed ID: 24607624
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic value of spleen stiffness by magnetic resonance elastography for prediction of esophageal varices in cirrhotic patients.
Jhang ZE; Wu KL; Chen CB; Chen YL; Lin PY; Chou CT
Abdom Radiol (NY); 2021 Feb; 46(2):526-533. PubMed ID: 32676734
[TBL] [Abstract][Full Text] [Related]
18. Spleen Stiffness Probability Index (SSPI): A simple and accurate method to detect esophageal varices in patients with compensated liver cirrhosis.
Giuffrè M; Macor D; Masutti F; Abazia C; Tinè F; Bedogni G; Tiribelli C; Crocè LS
Ann Hepatol; 2020; 19(1):53-61. PubMed ID: 31740162
[TBL] [Abstract][Full Text] [Related]
19. Measurement of spleen stiffness to evaluate portal hypertension and the presence of esophageal varices in patients with HCV-related cirrhosis.
Colecchia A; Montrone L; Scaioli E; Bacchi-Reggiani ML; Colli A; Casazza G; Schiumerini R; Turco L; Di Biase AR; Mazzella G; Marzi L; Arena U; Pinzani M; Festi D
Gastroenterology; 2012 Sep; 143(3):646-654. PubMed ID: 22643348
[TBL] [Abstract][Full Text] [Related]
20. Spleen stiffness: a new tool to predict high-risk varices in cirrhotic patients.
Gaspar R; Silva M; Cardoso P; Goncalves R; Andrade P; Macedo G
J Gastroenterol Hepatol; 2023 Oct; 38(10):1840-1846. PubMed ID: 37655720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
